Skip to Primary Content

Publix follows guidance and suspends administration of Johnson & Johnson COVID-19 vaccine

LAKELAND, Fla., April 13, 2021 — Following guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA), Publix is suspending the administration of the Johnson & Johnson COVID-19 vaccine at all of its pharmacy locations.

Customers can visit publix.com/covidvaccine to schedule an appointment for the Moderna COVID-19 vaccine, if currently available in their state.

The CDC and FDA have issued a joint media statement with additional information about the Johnson & Johnson COVID-19 vaccine. According to the CDC and FDA, while a rare side effect, individuals who have received the Johnson & Johnson COVID-19 vaccine should contact their health care provider if they develop a severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination.

Category

* Subject to Publix’s Media Use Policy. Editorial use only. Content remains the property of Publix and will be removed in Publix’s discretion. All rights reserved.

Asset Description Download Link
Publix pharmacy logo Publix pharmacy logo Download*
Publix pharmacy logo Publix pharmacy logo Download*
Publix pharmacy logo Publix pharmacy logo Download*